New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
February 21, 2013
08:54 EDTACHNAchillion shares should be bought on any weakness, says JMP Securities
After Achillion announced a financing deal that JMP Securities believes may cause the stock to retreat, the firm thinks the company is poised to report "transformative data" this year. The firm thinks the company's HCV treatments have no safety risks, and it reiterates a $15 price target and Outperform rating on the shares.
News For ACHN From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
April 24, 2015
12:22 EDTACHNAchillion spokesperson says EASL presentation not canceled, Bloomberg reports
Subscribe for More Information
11:22 EDTACHNAchillion strength attributed to rumor of canceling presentation
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use